Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Humoral immune response to epidermal growth factor receptor in lung cancer.

Immunologic research - 1 Feb 2021

Wang Yulin, Liu Fenghui, OuYang Songyun, Liu Man, Zhang Xue, Wang Peng, Zhao Chunling, Zhang Liguo, Dai Liping

Abstract excerpt

The aim of this study was to explore the potential value of autoantibody to epidermal growth factor receptor (EGFR) in the diagnosis of lung cancer (LC) and its relation with EGFR mutations. Enzyme-linked immunosorbent assay (ELISA) was performed to detect the level of autoantibody to EGFR in sera from 254 LC patients and 222 normal controls (NCs). Besides, the mRNA and protein levels of EGFR were investigated in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Autoantibodies
Share to Carcinoembryonic Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Carcinoma, Squamous Cell

Share to Immunity, Humoral

Share to Neoplasm Staging

Share to Predictive Value of Tests

Source

Identifiers

PMID: 33495907
DOI: 10.1007/s12026-021-09174-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Humoral immune response to epidermal growth factor receptor in lung cancer.PMID 33495907Read ↗

Serum carcinoembryonic antigen levels before initial treatment are associated with EGFR mutations and EML4- ALK fusion gene in lung adenocarcinoma patients.Semantic proximity Read ↗

Association between squamous cell carcinoma antigen level and EGFR mutation status in Chinese lung adenocarcinoma patients.Semantic proximity Read ↗

High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments.Semantic proximity Read ↗

Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma.Semantic proximity Read ↗

Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations.Semantic proximity Read ↗

Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma.Semantic proximity Read ↗

Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancerSemantic proximity Read ↗

Chitinase 3-like-1 (CHI3L1) in the Pathogenesis of Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung CancerSemantic proximity Read ↗

Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma.Semantic proximity Read ↗

An analysis of the influencing factors of false negative autoantibodies in patients with non-small cell lung cancerSemantic proximity Read ↗

The Biology of Epidermal Growth Factor Receptor in Lung CancerSemantic proximity Read ↗

Correlation between carcinoembryonic antigen (CEA) expression and EGFR mutations in non-small-cell lung cancer: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.